Literature DB >> 20680534

The patient-physician partnership in asthma: real-world observations associated with clinical and patient-reported outcomes.

M Small1, A Vickers, P Anderson, S Kay.   

Abstract

INTRODUCTION: It is hypothesized that a good partnership between asthma patients and their physicians has a direct and positive influence on the patients' clinical and patient-reported outcomes. Conversely, poor partnership has a detrimental effect on clinical and patient-reported outcomes. This paper uses data from a real-world observational study to define partnership through matched physician and patient data and correlate the quality of partnership with observed clinical and patient-reported outcomes.
METHODS: Data were drawn from Adelphi's Respiratory Disease Specific Programme, a cross-sectional study of consulting patients in five European countries undertaken between June and September 2009. A range of clinical and patient-reported outcomes were observed allowing analysis of the partnership between 2251 asthma patients and their physicians.
RESULTS: Analysis demonstrates that the better the partnership between patient and physician, the more likely the patient is to have their asthma condition controlled (P<0.001), to experience fewer exacerbations (P<0.001), to have better quality of life (P<0.001), to have fewer sleep disturbances (P<0.001), and to have fewer patient-reported symptoms (P<0.001). Partnership is also associated with lower impact on lifestyle (P<0.01) and reduced days lost at work/school (P<0.05), and with patient satisfaction with their inhaler device (P<0.05).
CONCLUSION: The patient-physician partnership is a contributory factor in the improvement of asthma treatment, and patient education may lead to improvement in a patient's ability to contribute to this. Device satisfaction is one of the markers of good partnership.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680534     DOI: 10.1007/s12325-010-0054-1

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  8 in total

1.  Impact of shared decision making on asthma quality of life and asthma control among children.

Authors:  Yhenneko J Taylor; Hazel Tapp; Lindsay E Shade; Tsai-Ling Liu; Jessica Lauren Mowrer; Michael F Dulin
Journal:  J Asthma       Date:  2017-10-11       Impact factor: 2.515

2.  Asthma action plans and patient satisfaction among women with asthma.

Authors:  Minal R Patel; Melissa A Valerio; Georgiana Sanders; Lara J Thomas; Noreen M Clark
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

3.  Cross-reactivity between aeroallergens and food allergens.

Authors:  Florin-Dan Popescu
Journal:  World J Methodol       Date:  2015-06-26

4.  Asthma in Head Start children: effects of the Breathmobile program and family communication on asthma outcomes.

Authors:  Michelle N Eakin; Cynthia S Rand; Andrew Bilderback; Mary E Bollinger; Arlene Butz; Veni Kandasamy; Kristin A Riekert
Journal:  J Allergy Clin Immunol       Date:  2011-11-21       Impact factor: 10.793

5.  Timing of emergency department visits for childhood asthma after initial inhaled corticosteroid use.

Authors:  George Rust; Shun Zhang; Kelvin Holloway; Yasmin Tyler-Hill
Journal:  Popul Health Manag       Date:  2014-07-21       Impact factor: 2.459

6.  Validation of the Polish version of Satisfaction with Asthma Treatment Questionnaire (SATQ).

Authors:  Katarzyna Dońka; Krzysztof J Czarnocki; Andrzej Emeryk
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

Review 7.  Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients.

Authors:  U S Björnsdóttir; S Gizurarson; U Sabale
Journal:  Int J Clin Pract       Date:  2013-06-16       Impact factor: 2.503

8.  Regular follow-up visits reduce the risk for asthma exacerbation requiring admission in Korean adults with asthma.

Authors:  Hye Jung Park; Min Kwang Byun; Hyung Jung Kim; Chul Min Ahn; Chin Kook Rhee; Kyungjoo Kim; Bo Yeon Kim; Hye Won Bae; Kwang-Ha Yoo
Journal:  Allergy Asthma Clin Immunol       Date:  2018-07-10       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.